相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Blockade of VEGF-induced GSK/β-catenin signaling, uPAR expression and increased permeability by dominant negative p38α
Jinling Yang et al.
EXPERIMENTAL EYE RESEARCH (2012)
Tyrosine Nitration of Prostacyclin Synthase Is Associated with Enhanced Retinal Cell Apoptosis in Diabetes
Ming-Hui Zou et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Abrogation of MMP-9 Gene Protects Against the Development of Retinopathy in Diabetic Mice by Preventing Mitochondrial Damage
Renu A. Kowluru et al.
DIABETES (2011)
Inhibition of Reactive Gliosis Attenuates Excitotoxicity-Mediated Death of Retinal Ganglion Cells
Bhagyalaxmi S. Ganesh et al.
PLOS ONE (2011)
Vascular Basement Membrane Thickening in Diabetic Retinopathy
Sayon Roy et al.
CURRENT EYE RESEARCH (2010)
High Glucose Increases Lysyl Oxidase Expression and Activity in Retinal Endothelial Cells: Mechanism for Compromised Extracellular Matrix Barrier Function
Argyrios Chronopoulos et al.
DIABETES (2010)
Role of Matrix Metalloproteinase-9 in the Development of Diabetic Retinopathy and Its Regulation by H-Ras
Renu A. Kowluru
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Antipermeability Function of PEDF Involves Blockade of the MAP Kinase/GSK/beta-Catenin Signaling Pathway and uPAR Expression
Jinling Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Diabetic Retinopathy: Current Management and Experimental Therapeutic Targets
Tayyeba K. Ali et al.
PHARMACOTHERAPY (2009)
Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice
Hideo Goto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes
Deepti Navaratna et al.
FASEB JOURNAL (2008)
Vascular endothelial growth factor in eye disease
J. S. Penn et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2008)
Role of NADPH oxidase in retinal vascular inflammation
Mohamed Al-Shabrawey et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes
Deepti Navaratna et al.
DIABETES (2007)
Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress
Renu A. Kowluru et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes
AB El-Remessy et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The emerging role of proteases in retinal ganglion cell death
SK Chintala
EXPERIMENTAL EYE RESEARCH (2006)
Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3
DH Platt et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)
AM Byrne et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Vascular endothelial growth factor and diabetic retinopathy: Role of oxidative stress
RB Caldwell et al.
CURRENT DRUG TARGETS (2005)
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier
SJ Giebel et al.
LABORATORY INVESTIGATION (2005)
Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells
GW Prager et al.
BLOOD (2004)
UPA and uPAR in fibrinolysis, immunity and pathology
A Mondino et al.
TRENDS IN IMMUNOLOGY (2004)
Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model
A Das et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Nitric oxide may prevent hypertension early in diabetes by counteracting renal actions of superoxide
MW Brands et al.
HYPERTENSION (2004)
High glucose-induced tyrosine nitration in endothelial cells: Role of eNOS uncoupling and aldose reductase activation
AB El-Remessy et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor
AB El-Remessy et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy
K Noda et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Human RPE cell lysis of extracellular matrix: functional urokinase plasminogen activator receptor (uPAR), collagenase and elastase
SG Elner et al.
EXPERIMENTAL EYE RESEARCH (2003)
Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization
JM Rakic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Diabetic retinopathy: More than meets the eye
TW Gardner et al.
SURVEY OF OPHTHALMOLOGY (2002)
Diabetic vascular dysfunction: Links to glucose-induced reductive stress and VEGF
RG Tilton
MICROSCOPY RESEARCH AND TECHNIQUE (2002)
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis
MS Pepper
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Differential interaction of plakoglobin and β-catenin with the ubiquitin-proteasome system
E Sadot et al.
ONCOGENE (2000)
分享论文
